Primary record
N-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]hexadecanamide
- 库存
- 7,977 克
- 纯度
- 98.3 %
- CAS
- 4201-62-1
化合物标识与属性
- CAS
- 4201-62-1
- PubChem CID
- 53477895
- SMILES
- CCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC
名称与同义词
- Lactosylceramide
- LacCer
- Cytopylin H
- LacCer(d18:1/16:0)
- CDw17 antigen
- C16LacCer
- C16:0LacCer
- lactosyl-n-acylsphingosine
- RefChem:1088319
- 4201-62-1
- N-Hexadecanoyl-lactosylceramide
- orb1694300
- SCHEMBL9362810
- CHEBI:84758
- N-Lignoceryl sphingosyl lactoside
- LacCer (d18:1/16:0)
- C46H87NO13
- Gal-beta1->4Glc-beta1->1'Cer
- C16 Lactosylceramide (d18:1/16:0)
- Lactosyl ceramide (d18:1/16:0)
- MFCD28789016
- AKOS040754843
- N-(hexadecanoyl)-1-b-lactosyl-sphing-4-enine
- D-Galactosyl-1,4-beta-D-glucosylceramide
- C16 Lactosyl Ceramide (d18:1/16:0)
- C16 Lactosylceramide (d18:1/16:0))
- HY-153830
- J187.534E
- D-lactosyl-beta-1,1' N-palmitoyl-D-erythro-sphingosine
- J3.697.092H
- beta-D-Galactosyl-1,4-beta-D-glucosylceramide
- c16 lactosyl(beta) ceramide (d18:1/16:0)
- G91375
- delta-Galactosyl-1,4-beta-delta-glucosylceramide
- N-(hexadecanoyl)-1-beta-lactosyl-sphing-4-enine
- beta-delta-Galactosyl-1,4-beta-delta-glucosramide
- Beta-delta-Galactosyl-1,4-beta-delta-Glucosylceramide
- Q27158044
- N-[(1S,2R,3E)-1-[(4-O-beta-D-Galactopyranosyl-beta-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide
- 1-O-(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)-Ceramide
- 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide
- beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-hexadecanoylsphingosine
- N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
- 1-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-delta-galactopyranosyl-beta-delta-glucopyranosyl)-Ceramide
- 1ylce-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- N-Hexadecanoyl-1-O-(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)sphingosine
- (2S,3R,4E)-2-(Hexadecanoylamino)-1-(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyloxy)-4-octadecen-3-ol
- [(2S,3R)-2-(Hexadecanoylamino)-3-hydroxy-4-octadecenyl]4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
- CDH
- Hexadecanamide, N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- Hexadecanamide,N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- N-[(2S,3R)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
- N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
- N-[(2S,3R,4E)-1-{[4-O-(beta-D-galactopyranosyl)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
- N-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]hexadecanamide